Innovation

More from Innovation

9 hours ago

5 Questions With Greg Gorgas, CEO Of Artelo Biosciences

Not only were we very successful at inventing, developing, and ultimately commercializing rituximab, the first monoclonal antibody approved by the FDA to treat cancer, but most of my former colleagues have often referred to IDEC as one of the best experiences of their career.